Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medicaid Pharmacy Policy topic
No spam. Unsubscribe anytime.
Bill to let Medicaid cover co‑pays when primary insurance formulary differs laid over for fiscal review
Summary
Senate File 143 would allow Medical Assistance to cover co‑payments when a primary insurer’s formulary differs, intended to reduce treatment delays that can lead to higher costs; the committee adopted a technical amendment and laid the bill over for a fiscal note.
Senator Bolden presented Senate File 143, a measure intended to reduce delays and gaps in prescription access when patients have dual coverage (private primary insurance and Medical Assistance as payer of last resort). The bill would allow Medical Assistance to pay co‑payments so patients can promptly obtain medications that clinicians prescribe when a medication appears on a primary insurer’s formulary but not on Medicaid’s formulary, avoiding treatment delays that can escalate into hospitalizations.
Testimony included a policy director who described a personal case in which a multi‑week delay in Medicaid prior authorization led to a new diagnosis of diabetes and subsequent emergency‑room visits; she estimated Medicaid paid approximately $8,000 more as a result of the delay. Committee counsel identified an existing statutory definition of “cost‑effective” in chapter 256B that bears on administrative determinations; senators discussed how the bill could reduce higher system costs from delayed treatment.
The committee adopted an A‑1 technical amendment clarifying language; Senator Bolden said the amendment did not change substance. The bill was laid over to obtain fiscal information and further review.
